Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena.
Iozzo
R V
RV
Department of Pathology, Anatomy and Cell Biology, Cellular Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. iozzo@lac.jci.tju.edu
San Antonio
J D
JD
D000818:Animals; D016228:Endothelial Growth Factors / Q000502:physiology; D005346:Fibroblast Growth Factors / Q000502:physiology; D019812:Heparan Sulfate Proteoglycans / Q000502:physiology*; D006801:Humans; D008222:Lymphokines / Q000502:physiology; D008955:Models, Cardiovascular; D009369:Neoplasms / Q000098:blood supply; D009389:Neovascularization, Pathologic / Q000503:physiopathology; D018919:Neovascularization, Physiologic; D015398:Signal Transduction; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D019812:Heparan Sulfate Proteoglycans; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D005346:Fibroblast Growth Factors